For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Gensia Pharmaceuticals, Inc.

USPTO Granted Patents = 14

Forward Citations = 1,044

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Harry E Gruber (7 out of 47 patents)

Clinton E Browne (6 out of 12 patents)

Ronald R Tuttle (5 out of 22 patents)

4. Paul J Marangos (3 out of 15 patents)

5. Robert S Hillman (2 out of 24 patents)

6. Jack W Reich (2 out of 2 patents)

7. Walter John Bochenko (1 out of 41 patents)

8. Charles J McPhee (1 out of 39 patents)

9. Bheemarao G Ugarkar (1 out of 17 patents)

10. Paul K Laikind (1 out of 11 patents)

11. Ernest K Metzner (1 out of 6 patents)

12. John M Pawelchak (1 out of 2 patents)

13. Bheemaro G Vgarkar (1 out of 1 patent)

14. Leonard P Miller (1 out of 3 patents)

15. Kevin M Mullane (1 out of 5 patents)

14 patents: Sort by Forward Citations

1. 5817640 - Methods of preventing tissue damage associated with decreased blood flow (1998-10-06),

2. 5733259 - Method and apparatus for closed loop drug delivery (1998-03-31),

3. 5658889 - Method and compounds for aica riboside delivery and for lowering blood (1997-08-19),

4. 5395970 - 1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanol (1995-03-07),

5. 5286252 - Diagnosis, evaluation and treatment of coronary artery disease by (1994-02-15),

6. 5236908 - Methods of treating injury to the central nervous system (1993-08-17),

7. 5234404 - Diagnosis, evaluation and treatment of coronary artery disease by (1993-08-10),

8. 5200525 - Anti-seizure compounds (1993-04-06),

9. 5187162 - Methods of treating neurodegenerative conditions (1993-02-16),

10. 5169388 - Pressure-activated medication dispenser (1992-12-08),

11. 5132291 - Antivirals and methods for increasing the antiviral activity of AZT (1992-07-21),

12. 5108363 - Diagnosis, evaluation and treatment of coronary artery disease by (1992-04-28),

13. 5088978 - Apparatus and method for iontophoretic transfer (1992-02-18),

14. 5082829 - AICA riboside prodrugs (1992-01-21),

Company Overview

Gensia Pharmaceuticals, Inc. is a biopharmaceutical company based in San Diego, California, specializing in the development and commercialization of innovative therapies for various medical conditions. The company focuses on advanced drug formulations and delivery systems, particularly in the fields of oncology and critical care. Gensia is committed to addressing unmet medical needs through its research initiatives and collaborations, aiming to enhance patient outcomes and improve quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#389 in San Diego, CA

#5,322 in California

#22,333 in US

#42,290 in the World

San Diego, CA, United States of America

Gensia Pharmaceuticals, Inc.

Forward Citations = 1,044

16 inventors:

Harry E Gruber (7 out of 47 patents)

Clinton E Browne (6 out of 12 patents)

Ronald R Tuttle (5 out of 22 patents)

4. Paul J Marangos (3 out of 15 patents)

5. Robert S Hillman (2 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gensia Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/gensia-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…